| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.007 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.008 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.078 | 0.009 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |